Total Cash Per Share 3.13 Total Debt (MRQ) 68.25B Total Debt to Equity (MRQ) 2,028.83% Current Ratio (MRQ) 0.66 Quick Ratio (MRQ) 0.43Full Balance Sheet » ABBV Cash Flow Statement Cash from Operations (TTM) 18.81B Cash from Investing (TTM) -20.82B Levered Free Cash Flow (TTM) 19....
P/FCF Price To Free Cash Flows Ratio Show more IFRS indicators Data provided by Financial Modeling Prep Quarterly Annual Income Statement 30/09/2024thousand USD30/06/2024thousand USD31/03/2024thousand USD31/12/2023thousand USD30/09/2023thousand USD30/06/2023thousand USD31/03/2023thousand USD31...
AbbVie's robust business performance continues to support our capital allocation priorities. Our cash balance at the end of December was approximately $5.5 billion and we expect to generate free cash flow approaching $17 billion in 2025, which includes roughly $2.7 billion of Skyrizi...
Visa Inc. (V) : Free Stock Analysis Report UnitedHealth Group Incorporated (UNH) : Free Stock Analysis Report Constellation Energy Corporation (CEG) : Free Stock Analysis Report AbbVie Inc. (ABBV) : Free Stock Analysis Report Precipio, Inc. (PRPO) : Free Stock Analysis Report Equinor ASA (...
Try Barchart Premier for Free [Bullish | Limited Profit]A covered call is a neutral to slightly bullish option strategy where you expect the underlying security to increase in value. The covered call option strategy is used to generate income, where you cover the option position by owning the...
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus.FREE 30 Day Trial Abbvie Inc(ABBV) 189.77-0.83(-0.44%)15:42 ET[NYSE] 189.76x 140189.82x 12 Realtimeby (Cboe BZX) Trader's Cheat Sheetfor Mon, Feb 10th, 2025 ...
And then second, just had a high-level question about cash flow. Was hoping that you could discuss prospects for operating cash flow, capex, and free cash flow. Thank you very much. Richard A. Gonzalez—Chairman of the Board and Chief Executive Officer ...
During the first quarter, AbbVie released positive Phase IIb results from interferon- free studies for the treatment of HCV and continues to enroll patients in a comprehensive Phase III program for genotype 1 HCV that involves combinations of ABT- 450; a protease inhibitor for HCV infection; ABT...
Market Cap $21B Current Price $132.74 NASDAQ: EXEL Exelixis Market Cap $9B Current Price $33.15 NYSE: BMY Bristol Myers Squibb Market Cap $120B Current Price $58.95 Premium Investing Services Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The ...
ABBV earnings call for the period ending March 31, 2024. Motley Fool Transcribing | Apr 26, 2024 Related Stocks NASDAQ: VRTX Vertex Pharmaceuticals Market Cap $124B Current Price $481.65 NASDAQ: ILMN Illumina Market Cap $15B Current Price ...